Industries > Pharma > Global Respiratory Diagnostics Market Report 2017-2027

Global Respiratory Diagnostics Market Report 2017-2027

Instruments & Devices, Assays & Reagents, Services & Software, Obstructive Sleep Apnoea (OSA) Diagnostics Tests, Imaging Diagnostic Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, Other Tests, Tuberculosis, Asthma, Lung Cancer, COPD, Other Diseases, Hospitals, Reference Laboratories, Physician Offices, Other End-Users

PUBLISHED: 08 June 2017
PAGES: 197
PRODUCT CODE: PHA0199
SUBMARKET: Diagnostics

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0199 Categories: , Tags: , , ,

The global respiratory diagnostics market is expected to grow at a CAGR of 7.1% in the first half of the forecast period. The market is expected to grow at a CAGR of 7.4% from 2017-2027. The market is estimated at $5.32bn in 2016 and $8.00bn in 2022. In 2016, The instruments and devices submarket held the largest market share at 57.7%, followed by the assays and reagents submarket at 23.8%.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 197-page report you will receive 56 tables and 118 figures – all unavailable elsewhere.

The 197-page report provides clear detailed insight into the global respiratory diagnostics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Respiratory Diagnostics market forecasts from 2017-2027

• This report also breaks down the revenue forecast for the global respiratory diagnostics market by product & service:
• Instruments and Devices
• Assays and Reagents
• Services and Software

The forecast of each submarket is further broken down by region (North America, Europe, Asia-Pacific, RoW)

• This report also breaks down the revenue forecast for the global respiratory diagnostics market by test type:
• Obstructive Sleep Apnoea (OSA) Diagnostic Tests
• Imaging Tests
• Traditional Diagnostic Tests
• Molecular Diagnostic Tests
• Other test type

The forecast of each submarket is further broken down by region (North America, Europe, Asia-Pacific, RoW)

• This report also breaks down the revenue forecast for the global respiratory diagnostics market by end-users:
• Hospitals/Clinic Laboratories
• Reference Laboratories
• Physician Offices
• Other end-users

The forecast of each submarket is further broken down by region (North America, Europe, Asia-Pacific, RoW)

• This report also breaks down the revenue forecast for the global respiratory diagnostics market by disease type:
• Tuberculosis
• Asthma
• Lung Cancer
• COPD
• Other diseases

The forecast of each submarket is further broken down by region (North America, Europe, Asia-Pacific, RoW)

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
• North America: the US and Rest of North America
• Europe: the UK, Germany, France, Spain, Italy, Russia and Rest
 of Europe
• Asia-Pacific: China, India, Japan, Rest of Asia-Pacific
• Rest of the World: Latin America, Middle East and Africa

Global Respiratory Diagnostics Market Report 2017-2027

The forecast of each region is further broken down by product & service, test type, end-users and disease type

• Our study discusses the drivers and restraints that affect the global respiratory diagnostics market. Our study also discusses Porter’s Five Forces analysis that influence the global respiratory diagnostics market

• Our study discusses the selected leading companies that are the major players in the respiratory diagnostics industry.

Visiongain’s study is intended for anyone requiring commercial analyses for the global respiratory diagnostics market. You find data, trends and predictions.

Buy our report today Global Respiratory Diagnostics Market Report 2017-2027: Instruments & Devices, Assays & Reagents, Services & Software, Obstructive Sleep Apnoea (OSA) Diagnostics Tests, Imaging Diagnostic Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, Other Tests, Tuberculosis, Asthma, Lung Cancer, COPD, Other Diseases, Hospitals, Reference Laboratories, Physician Offices, Other End-Users.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Respiratory Diagnostics Market Report 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Respiratory Diagnostics Market Report 2017-2027


Latest Pharma news

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032

The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.

29 September 2022

READ

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ